生物技術製藥 30 9 月, 2026 davesilver Oneness Biotech Advances SNS851 Obesity Drug Candidate to Multiple-Ascending Dose Phase I Trial Oneness Biotech (TW: Read More
Uncategorized生物技術製藥 30 9 月, 2026 davesilver Caliway’s CBL-514 Shows Significant, Sustained Pain Reduction in Phase II Dercum’s Disease Trial Taiwan’s Caliw Read More
生物技術製藥 24 9 月, 2026 davesilver Merry Life Biomedical Advances Global Phase II Trial of TML-6 for Early Alzheimer’s Disease Taiwan’s Merry Read More
生物技術製藥 22 9 月, 2026 davesilver Lai touts Taiwan’s precision oncology push President Lai Ching- Read More
製藥 21 9 月, 2026 davesilver Anxo Pharmaceutical’s AX251 Completes World’s First Patient Dosing Anxo Pharmaceutical Read More
製藥 10 9 月, 2026 davesilver Taiwan’s Bora Pharmaceuticals Posts Second-Highest Monthly Revenue of NT$2.18 Billion in August; Sale-Leaseback Deal to Add Over NT$16 Million in Annual Cash Flow Bora Pharmaceuticals Read More
